Correlation Between Verrica Pharmaceuticals and GRAIL, LLC

Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and GRAIL, LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and GRAIL, LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verrica Pharmaceuticals and GRAIL, LLC, you can compare the effects of market volatilities on Verrica Pharmaceuticals and GRAIL, LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of GRAIL, LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and GRAIL, LLC.

Diversification Opportunities for Verrica Pharmaceuticals and GRAIL, LLC

0.05

Correlation Coefficient

Verrica Pharmaceuticals  GRAIL, LLC

Significant diversification

The 3 months correlation between Verrica and GRAIL, is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and GRAIL, LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRAIL, LLC and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with GRAIL, LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRAIL, LLC has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and GRAIL, LLC go up and down completely randomly.

Pair Corralation between Verrica Pharmaceuticals and GRAIL, LLC

Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the GRAIL, LLC. But the stock apears to be less risky and, when comparing its historical volatility, Verrica Pharmaceuticals is 1.66 times less risky than GRAIL, LLC. The stock trades about -0.11 of its potential returns per unit of risk. The GRAIL, LLC is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,864  in GRAIL, LLC on December 29, 2024 and sell it today you would earn a total of  994.00  from holding GRAIL, LLC or generate 53.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Verrica Pharmaceuticals  vs.  GRAIL, LLC

Verrica Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Verrica Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

GRAIL, LLC

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in GRAIL, LLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, GRAIL, LLC disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Verrica Pharmaceuticals and GRAIL, LLC

The main advantage of trading using opposite Verrica Pharmaceuticals and GRAIL, LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, GRAIL, LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRAIL, LLC will offset losses from the drop in GRAIL, LLC's long position.

The idea behind Verrica Pharmaceuticals and GRAIL, LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.